Navigation Links
Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018
Date:11/9/2009

WALTHAM, Mass., Nov. 9 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies -- which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb -- were the highest-selling drug class in breast cancer treatment. Continued uptake of Herceptin and Tykerb/Tyverb and the expected launches of three new therapies will drive sales of HER2-targeting agents to grow by 3.3 percent per year from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

The new Pharmacor report entitled Breast Cancer finds that significant declines in sales in the hormonal therapy and chemotherapy segments of the market will be offset by a 1.2 percent annual increase in breast cancer incidence in the world's major markets and by the launch and uptake of premium-priced agents. Emerging HER2-targeting therapies that are expected to launch by 2018 include Roche/Chugai's Omnitarg, Roche's T-DM1 and Wyeth's HKI-272.

The report also finds that sales of Roche/Chugai's Avastin for breast cancer will increase by four percent from 2008 to 2018, largely owing to greater uptake by patients with metastatic disease.

"Since its approval, Avastin has garnered substantial patient share in metastatic breast cancer, particularly in the metastatic triple-negative and metastatic HR-refractory treatment settings, where there is a significant need for effective therapeutic options," said Decision Resources Analyst Niamh Murphy, Ph.D. "However, many of the physicians we interviewed, particularly in Europe, are not very enthusiastic about Avastin for breast cancer because they consider its cost-benefit profile suboptimal."

According to the report, experts are enthusiastic about the launch and uptake of a novel class of breast cancer
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Recession Continues to Depress Sales at Allied Healthcare Products
2. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
3. Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
4. DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
5. Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
6. HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation
7. University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President, International Sales
8. Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand Sales in the U.S. and Europe by 2018
9. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
10. $500 Billion Health Care Spend Boosts BRIC Countries Diagnostic Imaging Sales Despite Global Recession, According to Millennium Research Group
11. EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing & Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2010)... LOUIS , Feb. 8 Cost ... Healthcare Products (Nasdaq: AHPI ) narrowly back into ... ,, Sales for the quarter ended December 31, ... $12.5 million during the same quarter last year ... However, Allied,s costs of sales were reduced even more ...
(Date:2/8/2010)... EAST BRUNSWICK, N.J. , Feb. 8 /PRNewswire-FirstCall/ ... today that the company will release financial results for ... of the market on Thursday, February 25, 2010 ... David Gionco, Group Vice President and Chief Financial Officer, ... 10:00 a.m. Eastern Time on February ...
(Date:2/8/2010)... Feb. 8 Hanger Orthopedic Group, Inc. (NYSE: ... report its results of operations for the year ended ... . ,, The Company plans to issue a press release ... 2009 on Wednesday, February 10, 2010 , after ... to begin at 9:00 a.m., EST , on ...
Breaking Medicine Technology:Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 2Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 3Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 4Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 5Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 6Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010 2Hanger Orthopedic Group, Inc. Announces 2009 Year-End Earnings Release Conference Call 2New type of genetic change identified in inherited cancer 58828 1New type of genetic change identified in inherited cancer 58828 2New type of genetic change identified in inherited cancer 58828 3Study finds 231 new genes associated with head and neck cancer 10252 1Study finds 231 new genes associated with head and neck cancer 10252 21 Million Preemie Babies Die Each Year 3A Report 58826 11 Million Preemie Babies Die Each Year 3A Report 58826 21 Million Preemie Babies Die Each Year 3A Report 58826 3
... announced today the 28 recipients of the 2009 Seed Grant Research Program. ... physician residents and fellows to conduct basic science, applied or clinical research ... four categories: , , , ... HIV/AIDS , Leukemia , ...
... 6 B-R-A-H-M-S,Aktiengesellschaft today announced it has submitted ... (FDA) to market its patented B-R-A-H-M-S,MR-proANP Kryptor Test. ... (ANP) is predominantly produced in the atrium,of the ... in the,circulation. ANP is involved in natriuresis, diuresis, ...
Other Medicine Technology:AMA Foundation Announces Seed Grant Research Recipients 2AMA Foundation Announces Seed Grant Research Recipients 3FDA Submission of B-R-A-H-M-S MR-proANP Kryptor 2
(Date:2/9/2010)... Center have found a direct link between neighborhood ... in African American women. The study, which appears ... , is the first prospective study to examine ... of type 2 diabetes in a large, geographically ... diabetes is estimated to affect 20.6 million people ...
(Date:2/9/2010)... Texas , Feb. 9 ... and project coordinator for the University of North ... Health Science Center , was instrumental in recently identifying ... in the Patio 29 cemetery. ,, The Chilean ... lead geneticist for a process audit team of the ...
(Date:2/9/2010)... most comprehensive study to date of secondhand smoke exposure ... journal Addiction . The study, carried out by ... reveals that exposure to household secondhand smoke among children ... researchers wanted to find out if there were ways ... children in private households, and whether those levels were ...
(Date:2/9/2010)... more effective in persuading young women to use birth ... according to a new study. , Researchers found that ... teen pregnancy felt more vulnerable two weeks after watching ... using birth control. , However, those who watched a ... were unmoved, and had no change in their intentions ...
(Date:2/9/2010)... 2010) AcademyHealth today recognized research that improves patient ... Services Research (HSR) Impact Award. The WHO Surgical ... ensure adherence to basic safety standards of care. ... that clearly translated into policy and, ultimately, made ... W. David Helms, Ph.D. "The WHO Surgical Safety ...
Breaking Medicine News(10 mins):Health News:Neighborhood socioeconomic status and diabetes 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 3Health News:Exposure to secondhand smoke among children in England has declined since 1996 2Health News:TV drama can be more persuasive than news program, study finds 2Health News:TV drama can be more persuasive than news program, study finds 3Health News:TV drama can be more persuasive than news program, study finds 4Health News:2010 HSR Impact Award recognizes surgical safety research 2
... Island College Hospital in Brooklyn is in news for the ... Long Island College Hospital are investigating the circumstances that led ... the wrong side of a patient’s brain to remove a ... as stable after a corrective surgery was conducted on the ...
... After waging wars over many drug formulations the pharma majors ... set in motion by the dramatic announcement of Indian firm ... less than a U.S. dollar a day. Not to be ... own production of anti retroviral drugs for AIDS treatment. , ...
... 7 months was the first recipient of a bloodless ... America. The seven month old, Aiden Michael Rush, whose ... to receive transfusions. The boy received 20% of his ... the children’s hospital in Los Angeles. , To avoid ...
... overcome a major obstacle to treating brain ailments such ... studies in rats, researchers from the Stroke Lab and ... “a direct path from the nose to the brain” ... from foreign substances, including drugs. Senior investigator Dr. ...
... The gay capital? of the world, San Francisco is now reeling ... In the past one-year the rate of infection has actually doubled ... men, who are also intra venous drug users, the rates are ... ,Hold your breath! The successful control of spread of HIV ...
... is a gift, exclusive to the blessed. The less ... problems such as early morning headaches or serious daytime ... its mild or moderate form is commonly experienced. Sleep ... breathing during sleep. Most individuals may have less severe ...
Other Medicine News:Health News:Nasal Spray Could Take Drugs Direct to Brain. 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: